NCT03362398View on ClinicalTrials.gov

Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 20, 2017

Primary Completion Date

November 27, 2017

Study Completion Date

November 28, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Omarigliptin 25 mg

Once weekly new anti-diabetic drug approved only in Japan

DRUG

Trelagliptin 100 mg

Once weekly new anti-diabetic drug approved only in Japan

Trial Locations (1)

Unknown

The British University in Egypt, Cairo

All Listed Sponsors
lead

British University In Egypt

OTHER

NCT03362398 - Omarigliptin & Trelagliptin in Twelve Healthy Egyptian Volunteers | Biotech Hunter | Biotech Hunter